Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ovations Seeks To Be National Medicare Drug Plan Sponsor

This article was originally published in The Pink Sheet Daily

Executive Summary

Insurer notifies CMS of its intent to offer a national prescription drug plan, making it the second large health plan after Aetna to disclose such an intent. Ovations’ parent company, UnitedHealth Group, is the largest health plan client of Medco, which has also applied to sponsor a PDP.

You may also be interested in...



Medicare Rx Plan Candidates Down To The Wire: Applications Due March 23

CMS will accept applications from Part D prescription drug plans, Medicare Advantage drug benefit providers and cost contractors. Related reporting requirements are scheduled to be posted on CMS’ website in April.

Medicare Rx Plan Candidates Down To The Wire: Applications Due March 23

CMS will accept applications from Part D prescription drug plans, Medicare Advantage drug benefit providers and cost contractors. Related reporting requirements are scheduled to be posted on CMS’ website in April.

Ovations Chooses Walgreens PBM To Administer Medicare Part D Plan

The health plan says its choice of Walgreens reflects the consumer-based focus of the Part D market. Ovations parent company UnitedHealth Group is Medco's largest health plan client and continues to have a strong relationship with Medco with respect to the group-based business, Ovations says.

Related Content

Topics

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel